Background: Melanoma is a malignant neoplasia that shows high mortality when diagnosed in advanced stages. Early identification of high-risk patients for the development of melanoma metastases is the main strategy to reduce mortality. oBjective: To assess the influence of eight epidemiological and histopathologic features on the development of metastases in patients diagnosed with primary cutaneous melanoma. Methods: Our historical cohort comprised patients with invasive primary cutaneous melanoma seen between 1995 and 2012 at a public university hospital and a private oncologic surgery institution in Southeastern Brazil. The following variables were analyzed: gender, age, family history of melanoma, site of the primary tumor, clinical and histologic subtype, Breslow thickness, histologic ulceration and the mitotic index. Kaplan-Meier univariate test and multivariate Cox proportional hazard analysis were used to assess factors associated with disease-free survival. results: Five hundred and fourteen patients were enrolled. The univariate analysis identified the following significant risk factors: gender, age, site of the tumor, clinical and histologic subtype, Breslow thickness, histologic ulceration and mitotic index. Multivariate analysis included 244 patients and detected four significant prognostic factors: male gender, nodular clinical and histologic subtype, Breslow thickness > 4mm, and histologic ulceration. The mitotic index was not included in this analysis. study liMitations: Small number of patients in multivariate analysis. conclusions: The following prognostic factors to the development of melanoma metastasis were identified in the study: male gender, nodular histologic subtype, Breslow thickness > 4mm and ulceration.
INTRODUCTION
Melanoma is an aggressive tumor with high mortality when diagnosed in advanced stages. Its incidence is increasing drastically all over the world, as well as its cases of death. 1, 2 Despite promising therapeutic advances, treatments capable of significantly prolonging the survival of patients with metastasis have not yet been developed. For this reason, the main strategy to reduce mortality is based on the early identification of the primary tumor and of the patients at risk for metastatic disease. 3 Different risk factors for the development of cutaneous melanoma metastases were studied extensively. Clinical and epidemiological aspects such as age, gender and site of the tumor are associated to disease progression. 4 Certain histopathologic, immunologic, genetic and molecular characteristics were also implicated in the development of melanoma metastasis. 1, 5 Due to the alarming increase in the incidence of melanoma and to the high mortality rates from metastatic disease, the data of patients seen with primary melanoma in the department of dermatology of a university hospital and a private surgical oncology practice between 1995 and 2012 were analyzed with the aim of identifying prognostic factors for the development of metastasis in melanoma.
METHODS

Study Population
This is a historical cohort, with data collection from pa- with melanoma associated to giant congenital melanocytic nevus, 20 with multiple melanomas and 11 patients being followed in both services (table 1) . Therefore, 514 patients were included in the study.
The patients selected for the statistical analysis fulfilled the following inclusion criteria: diagnosis of invasive primary cutaneous melanoma confirmed by histopathology, age equal to or above The patients that were still being seen at the services during the time of data collection signed a consent form.
Anatomopathological examination
The diagnosis of cutaneous melanoma was performed by anatomopathological examination. At the service of dermatology, only one experienced dermatopathologist was responsible for the analysis of the cases. At the service of surgical oncology, the diagnosis was obtained by the validation or review of the reports by a pathologist with a wide experience in melanocytic lesions.
Follow-up
The time for the follow-up of patients was defined as the interval between the date of diagnosis of the primary cutaneous melanoma (time zero) and the date of the last consultation or the date of the diagnosis of melanoma metastasis, in the cases where the disease spread (date of outcome). Data from patients' files with a minimum follow-up of one month were included. Among patients with melanoma metastasis, the mean age was 53 years (±17 years) and the median was 51 years. For those without metastasis, the mean age was 54 years (±17 years) and the median 53 years. There was no statistically significant difference between the groups (p=0.697). The median duration of the cohort's follow-up was 24.7 months (ranging from 1 to 374). The median duration of follow-up for patients with metastasis was 12.2 months, significantly lower than those censored, which was 30.4 months (p<0.001).
Statistical analysis
Of the 514 patients, 447 (87%) were diagnosed with the disease in the previous 10 years ( Figure 1 ).
Analysis of disease-free survival
According to the univariate analysis by the Kaplan-Meier method and the log-rank test, the following variables were considered of risk for the occurrence of metastasis: male gender 
Multivariate analysis
The multivariate analysis was conducted using the Cox In the sample studied, male gender, nodular clinicopathological type, Breslow thickness >1mm and the presence of ulceration were considered prognostic factors for the occurrence of metastasis.
Other authors also found a poorer course of melanoma in men. 6, 7 According to Pollack et al., 4 men had a lower survival at 1
and 5 years, regardless of the age at melanoma diagnosis. Vries et al. 8 showed that men have a 1. Recently, Liljana Mervic, 9 who followed 7,338 patients in a German university, showed that women had lower risks of melanoma spread and a longer interval between the primary tumor and the first metastasis. Besides, that study showed that females develop metastasis with a more favorable prognosis, such as satellite or in-transit metastasis, when compared to those of males.
The reason for the lower risk of melanoma spread in women is still unknown. A possible explanation for this could be the fact that women pay more attention to their own bodies and seek medical care earlier. 10 Hormonal influence was also postulated as responsible for a longer survival in women, but recent studies suggest that melanoma is not hormone-dependent. 11, 12 In a recent study, Joosse et al.reported that oxygen free radicals, such as the superoxide anion and hydrogen peroxide, are involved in the mealanogenesis of the tumor. 13 The authors postulated that the oxidative stress, more pronounced in men, could be responsible for the increased ability of melanoma to spread.
Patients with nodular melanoma had a 2.89-fold higher risk for disease spread when compared to the superficial spreading and lentigo maligna melanoma types, parameters used as reference and analyzed as group, independently from the other variables analyzed.
The second highest risk type was acral melanoma. However, in the multivariate analysis, it did not reach statistical significance (HR: 1.50).
In 2010, Kunte et al. 14 20 It is believed that thicker lesions can represent more advanced tumors with more intrinsic biological aggressiveness than those with radial growth only.
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According to Brauer et al.,thick melanomas increase the risk of early metastasis (between six months to three years of the initial tumor), compared to late metastases, that occur after eight years of the primary tumor. 23 An increased risk of local or in-transit metastasis was seen with increased melanoma thickness in the study by Stucky et al. 24 According to Faries et al.,there was an increased risk of occult lymph node recurrence with thicker Breslow in patients with thin melanomas (<1mm). 25 The case-control study conducted by Sartore et al.detected an increased risk of sentinel lymph node micrometastasis with the increased thickness of the primary tumor. 26 The presence of ulceration was also considered an independent risk factor for the development of melanoma metastasis in this study. Many authors confirmed the importance of ulceration in the prognosis of melanoma and the reduction in disease-free survival and survival of patients. [27] [28] [29] According to Balch et al.,the presence of ulceration in patients with localized melanoma reduces survival in 5
years from 80% to 55%. 30 The authors also observed that lesions with histological ulceration are associated to nodular and thicker tumors.
Eigentler et al. showed the reduction in the 10-year survival in pa- tients with T2 and T3 tumors (stage I) when ulceration was present.
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However, this variable did not influence T1 (≤1mm) and T4 (>4mm) tumors. 31 Staging based on Breslow thickness and ulceration was the variable that most influenced 10-year survival in patients with localized melanoma in the study by Francken et al. 32 According to the univariate analysis, the presence of mitoses in the histopathology was a statistically significant variable for the occurrence of metastasis in patients (p<0.0001). However, it was not possible to analyze it with the Cox method, because there was no metastasis in patients without detectable mitosis within the tumor. This invalidated the statistical method and the variable was excluded from the multivariate analysis. We can assume that, due to the low p value in the univariate analysis, the presence of mitosis is important for the prediction of metastasis in the study population.
According to Murali et al.,the presence of mitosis correlated with the reduction in the time for disease recurrence. 33 The mitotic index was also significantly correlated to tumor thickness (Breslow thickness) and to the presence of ulceration, but was not independently significant in the overall survival of patients. Nagore et al. 34 also detected a higher risk of metastasis in those tumors with mitosis, as well as Karjalainen et al. 35 According to Gimotty et al., who studied 396 patients with thin melanoma, the patients diagnosed with metastasis within their tumors had a higher risk of recurrence in 10 years than those with a mitotic index of zero (HR=6.7). 36 Svobodová et al. demonstrated that the presence of mitosis in the histopathology was associated to the reduction in disease-free survival (RR=1.911). 27 It is postulated that the mitotic index is related to a worse melanoma prognosis because it reflects a superior proliferative index, what would facilitate the occurrence of more aggressive cellular clones with a higher potential to create metastases. 34, 37 The results of this study show that age was not an independent variable to predict the risk for metastasis (p>0.05). Even though the authors have not shown the influence of age in the recurrence of melanoma, what can actually have happened with the population in this study, another factor could explain the lack of association with age in the study sample: the lack of distinction between locoregional and distant metastases, grouped in a single outcome. 38, 39 Some authors postulate that the occurrence of lymph node metastasis is more common in younger individuals, and in contrast distant dissemination of the disease is lower and survival is higher in this group of patients. 28, 40, 41 Kretschmer et al. showed that patients younger than 40 years had a higher risk of sentinel lymph node metastasis. 42 However, this age group had a lower risk of local and distant disease, besides a longer specific survival. Thus, the highest rates of lymph node metastasis that occur in younger patients could have been similar to the higher rates of distant metastasis in older patients in this study, affecting the final result.
In this study, family history of melanoma did not alter the 
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Other considerations
It is worth highlighting that 266 (34.1%) patients were ex- It is important to highlight that the present study grouped the four types of metastasis (satellite, in-transit, lymph node and distant) in a single outcome. This can lead to dissonant results with studies previously published, where the metastases are studied separately according to the affected site.
CONCLUSION
Male gender, nodular clinicopathological type, Breslow thickness >4mm and the presence of ulceration were considered risk factors for the occurrence of metastasis in patients with primary cutaneous melanoma in this study. q
